1. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014 Apr; 383(9927): 1490-502. doi: 10.1016/S0140-6736(13)61649-9. [ DOI] [ PubMed] 2. Sihvola S, Kuosmanen L, Kvist T. Resilience and related factors in colorectal cancer patients: A systematic review. Eur J Oncol Nurs. 2022 Feb; 56: 102079. doi: 10.1016/j.ejon.2021.102079. [ DOI] [ PubMed] 3. Ansari R, Mahdavinia M, Sadjadi A, Nouraie M, Kamangar F, Bishehsari F, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett. 2006 Aug; 240(1): 143-47. doi: 10.1016/j.canlet.2005.09.004. [ DOI] [ PubMed] 4. Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in Iran: a systematic review and meta-analysis. BMC Public Health. 2015 Oct; 15: 997. doi: 10.1186/s12889-015-2342-9. [ DOI] [ PubMed] 5. Andrew AS, Parker S, Anderson JC, Rees JR, Robinson C, Riddle B, et al. Risk Factors for Diagnosis of Colorectal Cancer at a Late Stage: a Population-Based Study. J Gen Intern Med. 2018 Dec; 33(12): 2100-105. doi: 10.1007/s11606-018-4648-7. [ DOI] [ PubMed] 6. Kuipers EJ, Rösch T, Bretthauer M. Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol. 2013 Mar; 10(3): 130-42. doi: 10.1038/nrclinonc.2013.12. [ DOI] [ PubMed] 7. Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010 Nov; 11(7): 537-61. doi: 10.2174/138920210793175895. [ DOI] [ PubMed] 8. Tsukamoto M, Iinuma H, Yagi T, Matsuda K, Hashiguchi Y. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer. Oncology. 2017; 92(6): 360-70. doi: 10.1159/000463387. [ DOI] [ PubMed] 9. Hosseinahli N, Aghapour M, Duijf PHG, Baradaran B. Treating cancer with microRNA replacement therapy: A literature review. J Cell Physiol. 2018 Aug; 233(8): 5574-88. doi: 10.1002/jcp.26514. [ DOI] [ PubMed] 10. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006 Apr; 6(4): 259-69. doi: 10.1038/nrc1840. [ DOI] [ PubMed] 11. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000 Feb; 403(6772): 901-906. doi: 10.1038/35002607. [ DOI] [ PubMed] 12. Berindan-Neagoe I, Calin GA. Molecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res. 2014 Dec; 20(24): 6247-53. doi: 10.1158/1078-0432.CCR-13-2500. [ DOI] [ PubMed] 13. Mizuno R, Kawada K, Sakai Y. The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer. Can J Gastroenterol Hepatol. 2018 Jun; 2018: 5769591. doi: 10.1155/2018/5769591. [ DOI] [ PubMed] 14. Lynam-Lennon N, Maher SG, Reynolds JV. The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc. 2009 Feb; 84(1): 55-71. doi: 10.1111/j.1469-185X.2008.00061.x. [ DOI] [ PubMed] 15. Kita Y, Yonemori K, Osako Y, Baba K, Mori S, Maemura K, et al. Noncoding RNA and colorectal cancer: its epigenetic role. J Hum Genet. 2017 Jan; 62(1): 41-47. doi: 10.1038/jhg.2016.66. [ DOI] [ PubMed] 16. Wang Y, Le Y, Xue JY, Zheng ZJ, Xue YM. Let-7d miRNA prevents TGF-β1-induced EMT and renal fibrogenesis through regulation of HMGA2 expression. Biochem Biophys Res Commun. 2016 Oct; 479(4): 676-82. doi: 10.1016/j.bbrc.2016.09.154. [ DOI] [ PubMed] 17. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010 Jul; 127(1): 118-26. doi: 10.1002/ijc.25007. [ DOI] [ PubMed] 18. Wang WT, Zhao YN, Yan JX, Weng MY, Wang Y, Chen YQ, et al. Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol. 2014 Jan; 7: 6. doi: 10.1186/1756-8722-7-6. [ DOI] [ PubMed] 19. Cook NR. Methods for evaluating novel biomarkers - a new paradigm. Int J Clin Pract. 2010 Dec; 64(13): 1723-27. doi: 10.1111/j.1742-1241.2010.02469.x. [ DOI] [ PubMed] 20. Wei Y, Liu G, Wu B, Yuan Y, Pan Y. Let-7d Inhibits Growth and Metastasis in Breast Cancer by Targeting Jab1/Cops5. Cell Physiol Biochem. 2018; 47(5): 2126-35. doi: 10.1159/000491523. [ DOI] [ PubMed] 21. Eichelmann AK, Matuszcak C, Lindner K, Haier J, Hussey DJ, Hummel R. Complex role of miR-130a-3p and miR-148a-3p balance on drug resistance and tumor biology in esophageal squamous cell carcinoma. Sci Rep. 2018 Dec; 8(1): 17553. doi: 10.1038/s41598-018-35799-1. [ DOI] [ PubMed] 22. Shahabi A, Naghili B, Ansarin K, Montazeri M, Dadashpour M, Zarghami N. Let-7d and miR-185 Impede Epithelial-Mesenchymal Transition by Downregulating Rab25 in Breast Cancer. Asian Pac J Cancer Prev. 2021 Jan; 22(1): 305-13. doi: 10.31557/APJCP.2021.22.1.305. [ DOI] [ PubMed] 23. Kudelova E, Holubekova V, Grendar M, Kolkova Z, Samec M, Vanova B, et al. Circulating miRNA expression over the course of colorectal cancer treatment. Oncol Lett. 2022 Jan; 23(1): 18. doi: 10.3892/ol.2021.13136. [ DOI] [ PubMed] 24. Yang Y, Ma L, Qiao X, Zhang X, Dong SF, Wu MT, et al. Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion. Transl Lung Cancer Res. 2020 Aug; 9(4): 1247-57. doi: 10.21037/tlcr-19-530. [ DOI] [ PubMed] 25. Wang W, Wu LR, Li C, Zhou X, Liu P, Jia X, et al. Five serum microRNAs for detection and predicting of ovarian cancer. Eur J Obstet Gynecol Reprod Biol X. 2019 Apr; 3: 100017. doi: 10.1016/j.eurox.2019.100017. [ DOI] [ PubMed] 26. Abdel Ghany SM, Ali EM, Ahmed A, Hozayen W, Mohamed-Hussein A, Elnaggar M, et al. Circulating miRNA-30a and miRNA-221 as Novel Biomarkers for the Early Detection of Non-Small-Cell Lung Cancer. Middle East Journal of Cancer. 2020; 11(1): 50-58. doi: 10.30476/mejc.2019.81242.0. [ View at Publisher] [ DOI] |
